Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 3
2007 1
2008 7
2009 5
2010 5
2011 8
2012 6
2013 6
2014 7
2015 4
2016 2
2017 1
2018 4
2019 8
2020 7
2021 8
2022 12
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
TRUST-II: a global phase II study of taletrectinib in ROS1-positive non-small-cell lung cancer and other solid tumors.
Nagasaka M, Ohe Y, Zhou C, Choi CM, Yang N, Liu G, Felip E, Pérol M, Besse B, Nieva J, Raez L, Pennell NA, Dimou A, Marinis F, Ciardiello F, Seto T, Hu Z, Pan M, Wang W, Li S, Ou SI. Nagasaka M, et al. Among authors: dimou a. Future Oncol. 2023 Jan;19(2):123-135. doi: 10.2217/fon-2022-1059. Epub 2023 Mar 6. Future Oncol. 2023. PMID: 36877099 Free article.
Craniofacial Development Is Fine-Tuned by Sox2.
Mandalos NP, Dimou A, Gavala MA, Lambraki E, Remboutsika E. Mandalos NP, et al. Among authors: dimou a. Genes (Basel). 2023 Jan 31;14(2):380. doi: 10.3390/genes14020380. Genes (Basel). 2023. PMID: 36833308 Free PMC article. Review.
A network SIRX model for the spreading of COVID-19.
Dimou A, Maragakis M, Argyrakis P. Dimou A, et al. Physica A. 2022 Mar 15;590:126746. doi: 10.1016/j.physa.2021.126746. Epub 2021 Dec 8. Physica A. 2022. PMID: 34898823 Free PMC article.
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.
Smith KER, Peng KW, Pulido JS, Weisbrod AJ, Strand CA, Allred JB, Newsom AN, Zhang L, Packiriswamy N, Kottke T, Tonne JM, Moore M, Montane HN, Kottschade LA, McWilliams RR, Dudek AZ, Yan Y, Dimou A, Markovic SN, Federspiel MJ, Vile RG, Dronca RS, Block MS. Smith KER, et al. Among authors: dimou a. Front Immunol. 2023 Oct 31;14:1279387. doi: 10.3389/fimmu.2023.1279387. eCollection 2023. Front Immunol. 2023. PMID: 38022659 Free PMC article. Clinical Trial.
Advances in lung cancer.
Pacheco JM, Dimou A, Bunn PA. Pacheco JM, et al. Among authors: dimou a. Oncotarget. 2017 Sep 13;8(45):78247-78248. doi: 10.18632/oncotarget.20854. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108218 Free PMC article. No abstract available.
Inhibition of the Hedgehog pathway in lung cancer.
Dimou A, Bamias A, Gogas H, Syrigos K. Dimou A, et al. Lung Cancer. 2019 Jul;133:56-61. doi: 10.1016/j.lungcan.2019.05.004. Epub 2019 May 6. Lung Cancer. 2019. PMID: 31200829 Review.
New Developments in Neoadjuvant Therapy for Lung Cancer.
Bunn PA Jr, Schenk E, Pacheco J, Dimou A. Bunn PA Jr, et al. Among authors: dimou a. Oncology (Williston Park). 2019 Mar 13;33(3):101-6, 109. Oncology (Williston Park). 2019. PMID: 30866032 Free article. Review.
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial.
Hieken TJ, Nelson GD, Flotte TJ, Grewal EP, Chen J, McWilliams RR, Kottschade LA, Yang L, Domingo-Musibay E, Dronca RS, Yan Y, Markovic SN, Dimou A, Montane HN, Erskine CL, Piltin MA, Price DL, Khariwala SS, Hui J, Strand CA, Harrington SM, Suman VJ, Dong H, Block MS. Hieken TJ, et al. Among authors: dimou a. Nat Commun. 2024 Feb 16;15(1):1430. doi: 10.1038/s41467-024-45798-8. Nat Commun. 2024. PMID: 38365756 Free PMC article. Clinical Trial.
96 results